Tenax Therapeutics (TENX) Goodwill (2015 - 2016)

Tenax Therapeutics (TENX) reported Goodwill of $11.3 million for Q3 2016, little changed sequentially from $11.3 million in Q2 2016.

Tenax Therapeutics (TENX) Goodwill (2015 - 2016) Analysis & Trends

Tenax Therapeutics (TENX) has 2 years of Goodwill data on file, last reported at $11.3 million in Q3 2016.

For the quarter ending Q3 2016, Goodwill changed N/A year-over-year to $11.3 million; the trailing twelve-month figure through Sep 2016 stood at $11.3 million (changed N/A YoY), and the FY2015 full-year result was $11.3 million, changed N/A from the prior year.
Goodwill held at $11.3 million in Q3 2016, from $11.3 million in the prior quarter.
In the past five years, Goodwill ranged from a high of $11.3 million in Q4 2015 to a low of $11.3 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Tenax Therapeutics	67,856.40	67,856.40	-

Download Data